Explore the vast range of titles available.

An introduction to maritime communication through nautical flags, along with morse code, the phonetic alphabet, and semaphore signaling. Today's system of international maritime signal flags was developed in the 19th century, and is still used for communication between ships, or between ship and shore. Each flag, boldly colored for visual distinction at sea, stands for a letter as well as a phrase relevant to seafaring. The resulting code is both beautiful and functional, inviting readers to code and decode messages of their own! -- Source other than Library of Congress.

Inhibition of immune checkpoint molecules, PD‐1 and CTLA4, has been shown to be a promising cancer treatment. PD‐1 and CTLA4 inhibit TCR and co‐stimulatory signals. The third T cell activation signal represents the signals from the cytokine receptors. The cytokine interferon‐γ (IFNγ) plays an important role in anti‐tumor immunity by activating cytotoxic T cells (CTLs). Most cytokines use the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway, and the suppressors of cytokine signaling (SOCS) family of proteins are major negative regulators of the JAK/STAT pathway. Among SOCS proteins, CIS, SOCS1, and SOCS3 proteins can be considered the third immunocheckpoint molecules since they regulate cytokine signals that control the polarization of CD4+ T cells and the maturation of CD8+ T cells. This review summarizes recent progress on CIS, SOCS1, and SOCS3 in terms of their anti‐tumor immunity and potential applications. Inhibition of immune‐checkpoint molecules, PD‐1 and CTLA4, has been shown to be a promising cancer treatment. SOCS proteins are the third immune‐checkpoint molecules that inhibit cytokine signaling. This review is focusing on the mechanism of inhibition of cytokine signaling by CIS, SOCS1 and SOCS3, and their relationship to T cell biology and anti‐tumor immunity.

The SOCS family of proteins are negative-feedback inhibitors of signalling induced by cytokines that act via the JAK/STAT pathway. SOCS proteins can act as ubiquitin ligases by recruiting Cullin5 to ubiquitinate signalling components; however, SOCS1, the most potent member of the family, can also inhibit JAK directly. Here we determine the structural basis of both these modes of inhibition. Due to alterations within the SOCS box domain, SOCS1 has a compromised ability to recruit Cullin5; however, it is a direct, potent and selective inhibitor of JAK catalytic activity. The kinase inhibitory region of SOCS1 targets the substrate binding groove of JAK with high specificity and thereby blocks any subsequent phosphorylation. SOCS1 is a potent inhibitor of the interferon gamma (IFNγ) pathway, however, it does not bind the IFNγ receptor, making its mode-of-action distinct from SOCS3. These findings reveal the mechanism used by SOCS1 to inhibit signalling by inflammatory cytokines. Cytokines are key molecules in controlling haematopoiesis that signal via the JAK/STAT pathway. Here the authors present the structures of SOCS1 bound to its JAK1 target as well as in complex with elonginB and elonginC, providing a molecular explanation for the potent JAK- inhibitory activity of SOCS1.

\"Boy Scouts cofounder and avid outdoorsman \"Uncle Dan\" Beard researched the secret languages of trappers, hobos, steamer pilots, and Native American tribes to compile this comprehensive resource of pictographs and other encoded communication symbols. First published nearly a century ago, this practical reference provides Scouts and other lovers of the outdoors with an ever-useful guide to following trails and interpreting their surroundings. Uncle Dan leads readers from basic directional signs to danger signals of land and sea, chalk and map signs of animals, symbols of the elements, celestial characters, and marks of the seasons and of time. He explains common gesture language, signal codes, flag signaling, animal tracking, and a host of other well-illustrated signs, signals, and symbols. This timeless manual provides valuable insights that will enrich the adventures of hunters, campers, backpackers, Scouts, and other wilderness enthusiasts\"-- Provided by publisher.

ObjectivesAdult-onset Still’s disease (AOSD) is a rare systemic autoinflammatory disease; its management is largely empirical. This is the first clinical study to determine if interleukin (IL)-18 inhibition, using the recombinant human IL-18 binding protein, tadekinig alfa, is a therapeutic option in AOSD.MethodsIn this phase II, open-label study, patients were ≥18 years with active AOSD plus fever or C reactive protein (CRP) levels ≥10 mg/L despite treatment with prednisone and/or conventional synthetic disease-modifying antirheumatic drugs (DMARDs). Previous biological DMARD treatment was permitted. Patients received tadekinig alfa 80 mg or 160 mg subcutaneously three times per week for 12 weeks; those receiving 80 mg not achieving early predicted response criteria (reduction of ≥50% CRP values from baseline and fever resolution) were up-titrated to 160 mg for a further 12 weeks. The primary endpoint was the occurrence of adverse events (AEs) throughout the study.ResultsTen patients were assigned to receive 80 mg tadekinig alfa and 13 patients to the 160 mg dose. One hundred and fifty-five treatment-emerging AEs were recorded, and 47 were considered related to the study drug. Most AEs were mild and resolved after drug discontinuation. Three serious AEs occurred, one possibly related to treatment (toxic optic neuropathy). At week 3, 5 of 10 patients receiving 80 mg and 6 of 12 patients receiving 160 mg achieved the predefined response criteria.ConclusionsOur results indicate that tadekinig alfa appears to have a favourable safety profile and is associated with early signs of efficacy in patients with AOSD.Trial registration numberNCT02398435.

Key Points Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are a newly described family of intracellular sensors of microbial infections and danger signals. NLRs detect microbial motifs such as bacterial peptidoglycan (sensed by NOD1 and NOD2) or bacterial flagellin (sensed by NLR family, CARD-domain-containing 4 (NLRC4; also known as IPAF)) and NLR family, apoptosis inhibitory protein 5 (NAIP5). NLRs also sense danger signals, including uric acid, K + efflux, extracellular ATP, silica, asbestos and β-amyloid peptide through NLR family, pyrin domain-containing 3 (NLRP3). NLRs trigger innate immune responses by inducing signalling pathways, such nuclear factor-κB, mitogen-activated protein kinases, and the caspase 1 inflammasome. This results in the activation of inflammatory cytokines and/or chemokines. NLRs also work in synergy with Toll-like receptors to potentiate signal transduction pathways. Mutations in several NLR genes are associated with autoinflammatory disorders, including NOD2 (associated with Crohn's disease and Blau syndrome), NLRP3 (associated with Muckle–Wells syndrome, chronic infantile neurologic cutaneous and articular syndrome, and familial cold urticaria), NOD1 (associated with asthma, allergy and atopic eczema) and NLRP1 (associated with vitiligo). NLRs have a crucial role in the detection of molecules that were initially known as adjuvants, such as muramyl peptides and complete Freund's adjuvant (sensed by NOD1 and NOD2) and aluminium hydroxide (sensed by NLRP3). On detection of these molecules, NLRs shape the immune response to antigens, highlighting the link between NLRs and adaptive immunity. Because of their importance in innate immunity and adjuvanticity, NLRs and NLR-triggered pathways are promising target candidates for therapeutic strategies against autoinflammatory disorders. The recent development of interleukin 1-specific strategies against gout and Muckle–Wells syndrome illustrates the translation of NLR basic research into clinical practice. Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are a family of intracellular sensors that have key roles in innate immunity and inflammation. This Review discusses the effect that research on NLRs will have on vaccination, treatment of chronic inflammatory disorders and acute bacterial infections. Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are a family of intracellular sensors that have key roles in innate immunity and inflammation. Whereas some NLRs — including NOD1, NOD2, NAIP (NLR family, apoptosis inhibitory protein) and NLRC4 — detect conserved bacterial molecular signatures within the host cytosol, other members of this family sense 'danger signals', that is, xenocompounds or molecules that when recognized alert the immune system of hazardous environments, perhaps independently of a microbial trigger. In the past few years, remarkable progress has been made towards deciphering the role and the biology of NLRs, which has shown that these innate immune sensors have pivotal roles in providing immunity to infection, adjuvanticity and inflammation. Furthermore, several inflammatory disorders have been associated with mutations in human NLRgenes. Here, we discuss the effect that research on NLRs will have on vaccination, treatment of chronic inflammatory disorders and acute bacterial infections.

Inflammatory reactions are part of a complex biological response that plays a vital role in the appearance of various stimuli resulting from tissue and cell damage, the invasion of pathogenic bacteria, and the formation of the subsequent adaptive immune response. The production of many triggers and mediators of inflammation, which are inducers of pro-inflammatory factors, is controlled by numerous differentiation programs, through which inflammation is resolved and tissue homeostasis is restored. However, prolonged inflammatory responses or dysregulation of pro-inflammatory mechanisms can lead to chronic inflammation. Modern advances in biotechnology have made it possible to characterize the anti-inflammatory activity of phlorotannins, polyphenolic compounds from brown seaweed, and the mechanisms by which they modulate the inflammatory response. The purpose of this review is to analyze and summarize the results of numerous experimental in vitro and in vivo studies, illustrating the regulatory mechanisms of these compounds, which have a wide range of biological effects on the body. The results of these studies and the need for further research are discussed.

Inflammasomes are supramolecular complexes that form in the cytosol in response to pathogen-associated and damage-associated stimuli, as well as other danger signals that perturb cellular homoeostasis, resulting in host defence responses in the form of cytokine release and programmed cell death (pyroptosis). Inflammasome activity is closely associated with numerous human disorders, including rare genetic syndromes of autoinflammation, cardiovascular diseases, neurodegeneration and cancer. In recent years, a range of inflammasome components and their functions have been discovered, contributing to our knowledge of the overall machinery. Here, we review the latest advances in inflammasome biology from the perspective of structural and mechanistic studies. We focus on the most well-studied components of the canonical inflammasome — NAIP–NLRC4, NLRP3, NLRP1, CARD8 and caspase-1 — as well as caspase-4, caspase-5 and caspase-11 of the noncanonical inflammasome, and the inflammasome effectors GSDMD and NINJ1. These structural studies reveal important insights into how inflammasomes are assembled and regulated, and how they elicit the release of IL-1 family cytokines and induce membrane rupture in pyroptosis.This Review highlights new insights into the biology of inflammasomes from the perspective of structural and mechanistic studies, revealing how the supramolecular complexes that activate inflammatory caspases are assembled and regulated, to induce cytokine maturation and release, as well as pyroptotic cell death.

Gastric cancer (GC), a common and high-mortality disease, still occupies an important position in current cancer research, and Helicobacter pylori ( H. pylori ) infection as its important risk factor has been a hot and challenging research area. Among the numerous pathogenic factors of H. pylori , the virulence protein CagA has been widely studied as the only bacterial-derived oncoprotein. It was found that CagA entering into gastric epithelial cells (GECs) can induce the dysregulation of multiple cellular pathways such as MAPK signaling pathway, PI3K/Akt signaling pathway, NF-κB signaling pathway, Wnt/β-catenin signaling pathway, JAK-STAT signaling pathway, Hippo signaling pathway through phosphorylation and non-phosphorylation. These disordered pathways cause pathological changes in morphology, adhesion, polarity, proliferation, movement, and other processes of GECs, which eventually promotes the occurrence of GC. With the deepening of H. pylori -related research, the research on CagA-induced abnormal signaling pathway has been updated and deepened to some extent, so the key signaling pathways activated by CagA are used as the main stem to sort out the pathogenesis of CagA in this paper, aiming to provide new strategies for the H. pylori infection and treatment of GC in the future.